Life Sciences Drug DevelopmentAK
PanTher Therapeutics is leveraging targeted drug delivery and existing clinical paradigms for structural support to provide superior localized cancer therapies. With both a matrix and stent in development, PanTher is a platform technology with potential applications for pancreatic cancer as well as colorectal, esophageal, and mesothelioma. PanTher’s technology enhances therapeutic efficacy 12x the current standard of care by delivering a higher payload of drug directly to the tumor mass, drastically reducing tumor growth and metastasis. PanTher’s value proposition includes a reduction of overall healthcare costs by increasing the number of curable patients and minimizing repeated procedures.